Novel Withanolides from Tubocapsicum anomalum Suppress Triple-Negative Breast Cancer by Triggering Apoptosis and p53-ASCT2-SLC7A11-Mediated Ferroptosis
Molecules · 2024
DOI: 10.3390/molecules29081838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Lili Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Gaoke Rd., Hangzhou 311402, China. Hauptthemen laut MEDLINE: Ferroptosis, Triple Negative Breast Neoplasms, Tumor Suppressor Protein p53, Withanolides. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key Research Project of Traditional Chinese Medicine in Zhejiang Province, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) is a malignant breast cancer. There is an urgent need for effective drugs to be developed for TNBC. Tubocapsicum anomalum (T. anomalum) has been reported to have an anti-tumor effect, and six novel withanolides were isolated from it and designated as TAMEWs. However, its anti-TNBC effect is still unknown. The results of an MTT assay indicated a higher sensitivity of TNBC cells to TAMEWs compared to other cells. TAMEWs induced apoptosis via mitochondrial dysfunction. They caused increased levels of lipid ROS and Fe2+, with downregulation of GSH and cystine uptake, and it has been confirmed that TAMEWs induced ferroptosis. Additionally, the results of Western blotting indicate that TAMEWs significantly decrease the expressions of ferroptosis-related proteins. Through further investigation, it was found that the knockdown of the p53 gene resulted in a significant reversal of ferroptosis and the expressions of its associated proteins SLC7A11, ASCT2, and GPX4. In vivo, TAMEWs suppressed TNBC growth with no obvious damage. The IHC results also showed that TAMEWs induced apoptosis and ferroptosis in vivo. Our findings provide the first evidence that TAMEWs suppress TNBC growth through apoptosis and ferroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Gaoke Rd., Hangzhou 311402, China.
- The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou 310022, China.
- Academy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Binwen Rd., Hangzhou 310053, China.
Förderung
- the Key Research Project of Traditional Chinese Medicine in Zhejiang Province
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- the Key project joint construction by Science and Technology Department of National Administration of TCM and Zhejiang Administration of TCM
Zitieren
APA
Huang, L., Wei, Y., Ni, M., Hu, H., Xi, L., Wang, C., Zhu, Z., Yang, B., & Zhao, H. (2024). Novel Withanolides from Tubocapsicum anomalum Suppress Triple-Negative Breast Cancer by Triggering Apoptosis and p53-ASCT2-SLC7A11-Mediated Ferroptosis. Molecules. https://doi.org/10.3390/molecules29081838
Vancouver
Huang L, Wei Y, Ni M, Hu H, Xi L, Wang C, et al. Novel Withanolides from Tubocapsicum anomalum Suppress Triple-Negative Breast Cancer by Triggering Apoptosis and p53-ASCT2-SLC7A11-Mediated Ferroptosis. Molecules. 2024. doi:10.3390/molecules29081838
BibTeX
@article{Huang2024,
author = {Huang, Lili and Wei, Yingying and Ni, Maowei and Hu, Hongtao and Xi, Luyi and Wang, Chen and Zhu, Zhihui and Yang, Bo and Zhao, Huajun},
title = {Novel Withanolides from Tubocapsicum anomalum Suppress Triple-Negative Breast Cancer by Triggering Apoptosis and p53-ASCT2-SLC7A11-Mediated Ferroptosis},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29081838}
}
EUVIMED